Authors
M.A. Keller
Executive, National Laboratories; Senior Director, American Rare Donor Program, American Red Cross, Philadelphia, United States
C. Flickinger
Clinical Research Professional, Siemens Healthcare Diagnostics, Newark, United States
Managing Editor, Immunohematology, American Red Cross, Philadelphia, United States